0 Commentaires
0 Parts
1KB Vue
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Blogs
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Epidermal Growth Factor Receptor Inhibitor Market Global Industry Overview and ForecastThe global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...0 Commentaires 0 Parts 355 Vue
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentaires 0 Parts 1KB Vue
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentaires 0 Parts 1KB Vue
-
United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...0 Commentaires 0 Parts 34 Vue
-
Uterine Carcinosarcoma Market Size, Share and Trends Forecast to 2029According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market Data Bridge Market Research analyses a growth rate in the global uterine carcinosarcoma market in the forecast period 2022-2029. The expected CAGR of global uterine carcinosarcoma market is tend to be around 6.50% in the mentioned forecast period. The market was valued at...0 Commentaires 0 Parts 134 Vue
© 2026 Khajiit Nation
French